Core Insights - Safety Shot, Inc. is expanding its patented wellness approach into the high-growth cognitive and restorative sleep markets, focusing on scientific rigor and unique formulations [1][3] - The company aims to leverage its expertise in developing its existing product, Sure Shot, to create new nootropic and sleep aid products [3][4] Company Developments - Safety Shot is initiating research and development for new product lines targeting nootropics and sleep aids, with prototypes expected later this year [1][6] - The company emphasizes a commitment to efficacy and tangible results, with a focus on advanced technologies to create distinct advantages in the market [4][6] Market Potential - The global nootropics supplements market is valued at approximately $6.5 billion and is projected to exceed $14.9 billion by 2034, with a compound annual growth rate (CAGR) of 8.7% [5] - The sleep-related supplements market was valued at $6.8 billion in 2023, with an anticipated CAGR of 5.1%, reaching $11.8 billion by 2034 [5] Product Focus - The new nootropic product will be engineered to enhance focus, cognition, and overall brain health for daily use [7] - The sleep aid aims to improve sleep quality and duration, addressing the critical role of sleep in productivity and mental clarity, with a unique formulation not typically found in existing products [7]